相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU
Christina Creel-Bulos et al.
SHOCK (2021)
Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer
Sufang Tian et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
Targeting potential drivers of COVID-19: Neutrophil extracellular traps
Betsy J. Barnes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae
Hau C. Kwaan
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2020)
Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection
Franklin L. Wright et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2020)
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Songping Cui et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19
Claire S. Whyte et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Endothelial cell infection and endotheliitis in COVID-19
Zsuzsanna Varga et al.
LANCET (2020)
Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans
Sharon E. Fox et al.
LANCET RESPIRATORY MEDICINE (2020)
COVID-19 and pneumonia: a role for the uPA/uPAR system
Daniele D. ' Alonzo et al.
DRUG DISCOVERY TODAY (2020)
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
Hanny Al-Samkari et al.
BLOOD (2020)
Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome
Elizabeth A. Middleton et al.
BLOOD (2020)
Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis
Florian Langer et al.
HAMOSTASEOLOGIE (2020)
Neutrophil extracelluar traps in COVID-19
Yu Zuo et al.
JCI INSIGHT (2020)
Fibrinolysis and COVID-19: A plasmin paradox
Robert L. Medcalf et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation
Annabel Blasi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis
Christophe Nougier et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
F. A. Klok et al.
THROMBOSIS RESEARCH (2020)
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
Corrado Lodigiani et al.
THROMBOSIS RESEARCH (2020)
Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis
Panagiotis Skendros et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
The S100A10 Pathway Mediates an Occult Hyperfibrinolytic Subtype in Trauma Patients
Lewis S. Gall et al.
ANNALS OF SURGERY (2019)
Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation
Toshiaki Iba et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Upregulation of P2Y2R, Active uPA, and PAI-1 Are Essential Components of Hantavirus Cardiopulmonary Syndrome
Virginie Bondu et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury
Cong Liu et al.
FRONTIERS IN IMMUNOLOGY (2018)
A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC
Toshiaki Iba et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2018)
Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis
Travis J. Gould et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Basic mechanisms and regulation of fibrinolysis
C. Longstaff et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
The incidence and magnitude of fibrinolytic activation in trauma patients
I. Raza et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Nebulized Fibrinolytic Agents Improve Pulmonary Fibrinolysis but Not Inflammation in Rat Models of Direct and Indirect Acute Lung Injury
Jorrit J. Hofstra et al.
PLOS ONE (2013)
Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
Lisa E. Gralinski et al.
MBIO (2013)
The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice
Anthony J. Courey et al.
BLOOD (2011)
Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1
Mirjam E. Meltzer et al.
BLOOD (2010)
The plasminogen activation system in lung disease
T. H. Sisson et al.
CURRENT DRUG TARGETS (2007)
Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products
Miriam E. R. Darnell et al.
TRANSFUSION (2006)